SpineGuard
SpineGuard designs and supplies PediGuard handheld surgical instruments with proprietary DSG electrical-conductivity sensing technology, providing spine surgeons real-time audio feedback to avoid pedicle breaches during screw placement, sold to hospitals across 30+ countries.
- Company typePublic
- Founded2009
- HeadquartersVincennes, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What SpineGuard does
SpineGuard is a French publicly-traded medical device company (Euronext Growth Paris: ALSGD), founded in 2009 and headquartered in Vincennes near Paris. It designs, manufactures, and supplies a portfolio of single-use handheld surgical drilling instruments under the PediGuard brand, differentiated by its proprietary DSG (Dynamic Surgical Guidance) technology. DSG uses a bipolar sensor at the instrument tip to measure electrical conductivity of tissues at 5 Hz and emits real-time audio cues that allow spine surgeons to distinguish cancellous bone, cortical bone, and soft tissue, anticipating pedicle wall breaches during screw placement. The product line spans Straight, Curved, Cannulated, Threaded, and XS variants, complemented by the DSG Connect tablet application platform and an extension into sacroiliac joint fusion via the PsiFGuard device developed in partnership with Omnia Medical.
The company serves spine surgeons and hospitals performing spinal fusion, deformity correction, scoliosis treatment, minimally invasive procedures, and sacroiliac fusion. It generates revenue primarily through hardware sales of sterile single-use devices to hospitals and spine surgery centers, with pricing determined by institutional procurement rather than public list rates. Following the April 2026 transfer of its US subsidiary, SpineGuard commercializes in the US exclusively through Omnia Medical while retaining direct sales in Europe and distribution partnerships with XinRong Medical in China and WishBone Medical in US pediatric markets. The platform is FDA-cleared, CE-marked, EC-MDR certified, NMPA-approved in China, and registered in more than 30 countries, supported by 39 peer-reviewed publications and over 110,000 surgeries performed using DSG technology.
Operationally, SpineGuard is a sub-scale specialist with 11-50 employees and FY2025 revenue of €3,757K, currently operating at a loss while pursuing operational breakeven by end of 2026. The company is also extending DSG into surgical robotics (via Sorbonne University, CNRS/Inserm, and the FAROS Horizon 2020 consortium) and into dental implantology, building a long-term platform thesis around real-time bone-tissue sensing across multiple implant procedures.
SpineGuard firmographics
Firmographics- Name
- SpineGuard
- Legal name
- SpineGuard
- Website
- https://spineguard.com
- Company type
- Public
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SpineGuard designs and supplies PediGuard handheld surgical instruments with proprietary DSG electrical-conductivity sensing technology, providing spine surgeons real-time audio feedback to avoid pedicle breaches during screw placement, sold to hospitals across 30+ countries.
- Ownership category
- akta.pro rank
SpineGuard industry classification
Industry- Product category
- Spine Surgery Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
- akta.pro secondary industries
- Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
Keywords
Where SpineGuard is headquartered
LocationHeadquarters
- HQ city
- Vincennes
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
SpineGuard business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- PediGuard Device Sales: SpineGuard generates revenue primarily through the sale of its PediGuard devices with DSG technology. These are single-use, sterile surgical instruments sold to hospitals and spine surgery centers globally. Revenue is recognized upon product delivery.
- Distribution and Licensing Revenue: Following the US asset transfer to Omnia Medical, SpineGuard supplies PediGuard devices to Omnia Medical as the exclusive US distributor, generating recurring revenue through product supply agreements. The company also receives licensing considerations from various partnership arrangements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | PediGuard product line pricing (specific tiers not disclosed) |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
SpineGuard product offering
Product offeringCore offering
SpineGuard designs, manufactures, and commercializes the PediGuard family of single-use, sterile surgical drilling instruments equipped with proprietary DSG (Dynamic Surgical Guidance) technology. DSG measures tissue electrical conductivity in real time to detect potential vertebral cortical breaches during pedicle screw placement, providing audio feedback to surgeons without requiring X-ray imaging. The portfolio extends to the DSG Connect digital tablet platform, PsiFGuard for sacroiliac joint fusion, and DSG integrations for orthopedic robotics and dental implantology.
Product overview
SpineGuard has developed a platform-based product portfolio centered on its proprietary DSG (Dynamic Surgical Guidance) technology, which provides real-time electrical conductivity-based tissue sensing for skeletal implant placement. The core product line consists of the PediGuard family of drilling instruments available in multiple variants: Straight, Curved, Cannulated, Threaded, and XS models. These handheld devices alert surgeons in real-time to potential vertebral cortical breaches during pedicle screw placement. The DSG Connect platform adds a digital tablet interface for enhanced monitoring. Recent expansion includes PsiFGuard for sacroiliac joint fusion and applications for orthopedic robotics and dental implantology. The company also developed an ultrasound technology for robot-assisted surgery in collaboration with Sorbonne University.
Differentiator
Problem solved
Functional benefit
Brands
- PediGuard: Handheld drilling devices with DSG technology for secure pedicle screw placement in spine surgery
- DSG Connect
- DSG (Dynamic Surgical Guidance)
- PsiFGuard
Products and services
- PediGuard Straight
Quantifiable outcome
- 97% screw placement accuracy including in osteoporotic patients
- +8 more outcomes
Companies that use SpineGuard
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
SpineGuard technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
SpineGuard partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, secondary and minor.
- Omnia MedicalcoreSpineGuard completed the transfer of SpineGuard Inc. assets and entered an exclusive US distribution agreement for PediGuard devices. Omnia Medical assumed full commercialization responsibility, integrating the technology into its spine implant portfolio focused on minimally invasive and outpatient procedures. SpineGuard continues designing and manufacturing while supplying products to Omnia Medical. The transaction is expected to reduce SpineGuard's structural costs and supports its objective of achieving operational breakeven by end of 2026.
- Omnia Medical (PsiF Guard Technology)corePartnership for development of PsiF Guard technology integrated into Omnia Medical's PsiF DNA Sacroiliac Joint Stabilization System. The technology provides real-time intraoperative guidance for sacroiliac joint fusion procedures. FDA-cleared in May 2025 with commercial launch in January 2026.
- Sorbonne UniversitysecondaryCollaboration with Sorbonne University for development of new ultrasound robot-assisted technology for spine surgery. The technology allows determination of entry points and trajectories without X-rays. PhD thesis by Andrés Pérez Velásquez presented positive results validating the technology.
- XinRong Medical GroupcoreExpanded collaboration in China to include distribution, registration funding, and potential co-development of DSG technology-based spinal surgery devices. In July 2023, XinRong placed a large purchase order of 448 PediGuard units and invested €500,000 through capital increase to fund regulatory approval in China. The partnership leverages SpineGuard's DSG technology in China, the world's second-largest spinal market, with focus on market access and new device development. Three new PediGuard models (Curved and XS) received NMPA clearance in December 2025.
- Omnia Medical (Strategic Alliance)coreStrategic alliance announced for adult spine surgery in the United States, marking the beginning of the partnership that evolved into the April 2026 asset transfer and exclusive distribution agreement.
- CNRS and InsermsecondaryNew partnership with Sorbonne, CNRS and Inserm to associate DSG technology with ultrasound and serve surgical robots, expanding the technology platform for robotic applications.
- WishBone MedicalsecondaryNational distribution agreement for US pediatric orthopedic centers. New partnership to broaden access for pediatric orthopedic surgeons performing spine surgery.
- FAROS Consortium (Horizon 2020)minorSpineGuard joined the Horizon 2020 project FAROS (Functional Accurate RObotic Surgery) as consortium member. The European project focuses on robotic surgery development.
- ConfiDentminorExpansion of strategic partnership with ConfiDent, building on existing collaboration relationship.
- ISIR (Institut des Systèmes Intelligents et de la Robotique)secondaryCollaboration started in 2017 for application of DSG technology to surgical robots and enhancement of their safety, accuracy, and autonomy.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
SpineGuard competitors and assessment
Company assessmentBroad incumbents
- Zimmer Biomet: Orthopedic device company with ROSA Spine robotic system and broader spine implant portfolio. Comparable as a large incumbent offering computer-assisted spine surgery that competes with SpineGuard's handheld DSG concept.
- Stryker: Diversified medical device company with spine navigation offerings (SpineMap, Q Guidance System) and orthopedic robotics. Comparable to SpineGuard as an incumbent offering computer-assisted spine surgery in hospital settings, with far greater scale and resources.
- NuVasive: Spine surgery specialist (now part of Globus Medical) known for less-invasive and intraoperative neuromonitoring solutions. Comparable as a focused spine incumbent whose products and approach to surgical precision and safety parallel SpineGuard's positioning.
- Brainlab: Established surgical navigation and planning software company with strong presence in spine and neurosurgery. Competes in the same intraoperative guidance category as SpineGuard but with a much broader software-and-hardware platform and global installed base.
- Medtronic: Global leader in spinal surgery with StealthStation surgical navigation and Mazor robotic spine systems. While much larger and broader than SpineGuard, Medtronic defines the competitive landscape in spine surgical guidance and robotics, and its integrated platforms compete with SpineGuard's standalone handheld DSG approach.
- Globus Medical: Major spine device company offering ExcelsiusGPS robotic navigation platform. Following its merger with NuVasive, Globus Medical is one of the largest spine competitors and represents the integrated navigation-plus-implants model that SpineGuard must compete against.
- Orthofix: Spine and orthopedic device company offering spine hardware, biologics, and enabling technologies. Comparable as a mid-sized spine incumbent whose product portfolio overlaps SpineGuard's end customers (spine surgeons and hospitals).
Emerging players
- Augmedics: Emerging surgical navigation company offering xvision augmented-reality guidance for spine surgery. Comparable as a smaller, focused competitor developing next-generation spine navigation, though differentiated by its AR-based approach versus SpineGuard's conductivity sensing.
- Proprio Vision: Emerging surgical guidance company using light field technology and computer vision for spine and orthopedic procedures. Comparable as a smaller, technology-forward navigation company competing for the same surgeon mindshare in intraoperative spine guidance.
Direct peers
- 7D Surgical: Spine surgical navigation company using machine-vision technology for radiation-free screw placement. Most directly comparable to SpineGuard as a focused, smaller company offering intraoperative guidance for pedicle screw placement with similar value proposition around reducing radiation exposure.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SpineGuard social profiles
Digital presenceSpineGuard compliance and trust
Trust signalCompliance8 records
SpineGuard financial estimates
Financial estimateRevenue estimate
Valuation estimate
SpineGuard leadership team
Management profileNumber of profiles
Profiles12 records
SpineGuard subsidiaries and ownership
Company hierarchySubsidiaries1 record
SpineGuard funding detail
Funding detailFunding overview
Funding rounds10 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SpineGuard M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SpineGuard
What does SpineGuard do?
SpineGuard designs, manufactures, and commercializes the PediGuard family of single-use, sterile surgical drilling instruments equipped with proprietary DSG (Dynamic Surgical Guidance) technology. DSG measures tissue electrical conductivity in real time to detect potential vertebral cortical breaches during pedicle screw placement, providing audio feedback to surgeons without requiring X-ray imaging. The portfolio extends to the DSG Connect digital tablet platform, PsiFGuard for sacroiliac joint fusion, and DSG integrations for orthopedic robotics and dental implantology.
Is SpineGuard a public or private company?
SpineGuard is a public company. It is classified as public and is currently operating.
When was SpineGuard founded?
SpineGuard was founded in 2009. It employs 11 to 50 people.
Where is SpineGuard based?
SpineGuard is headquartered in Vincennes, France, in the Europe region.
How does SpineGuard make money?
Two revenue lines are on record. PediGuard Device Sales are the primary driver. The others are distribution and Licensing Revenue.
Who are SpineGuard's main competitors?
Broad incumbents on record are Zimmer Biomet, Stryker, NuVasive, Brainlab, Medtronic, Globus Medical and Orthofix. Emerging players are Augmedics and Proprio Vision. 7D Surgical is listed as a direct peer.
Does SpineGuard have an API?
No public API is recorded for SpineGuard.
What industry is SpineGuard in?
SpineGuard's product category is Spine Surgery Medical Devices. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.